HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

dihydrotestosterone propionate

RN given refers to (5alpha,17beta)-isomer; structure

Also Known As:

androstanolone propionate; dihydrotestosterone propionate, (5beta,17beta)-isomer

Networked: 12 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Polycyclic Compounds: 6
- Fused-Ring Compounds
  - Steroids: 70059
    - Androstanes: 11
      - Androstanols
        Dihydrotestosterone: 1732
        dihydrotestosterone propionate: 12
Hormones, Hormone Substitutes, and Hormone Antagonists
- Hormones: 80400
  - Gonadal Hormones: 716
    - Gonadal Steroid Hormones: 7657
      - Testosterone Congeners: 112
        Dihydrotestosterone: 1732
        dihydrotestosterone propionate: 12

Experts

1.	Marengo, Susan Ruth: 1 article (04/2006)
2.	Resnick, Martin I: 1 article (04/2006)
3.	Vykhovanets, Eugene V: 1 article (04/2006)
4.	Cochrane, D E: 1 article (06/2000)
5.	Feldberg, R S: 1 article (06/2000)
6.	Harris, M T: 1 article (06/2000)
7.	Lau, K M: 1 article (06/2000)
8.	Lazarus, N H: 1 article (06/2000)

Related Diseases

1.	Breast Neoplasms (Breast Cancer) 01/01/1962 - "Antitumor efficacy of 2alpha-methyl dihydrotestosterone propionate in advanced breast cancer." 06/14/1970 - "[Treatment of advanced stage of cancer of the breast with 2-alpha methyl dihydrotestosterone propionate (CS 1507]."
2.	Lordosis 01/01/1976 - "To test this, we treated hypox-ovx rats with dihydrotestosterone propionate (DHT-P), which suppresses plasma LH levels but is relatively ineffective in inducing sexual receptivity, and found a significant depression of lordosis responsiveness. " 04/01/1986 - "Single injections of dihydrotestosterone propionate (DHTP), also injected 48 h prior to testing, inhibited lordosis behaviour in EB-primed female rats. " 12/01/1989 - "In the present experiments, dihydrotestosterone propionate (200 micrograms for 3 days) inhibited the incidence of lordosis in ovariectomized females treated with estradiol benzoate (1 microgram for 3 days). " 12/01/1983 - "Treatment with either testosterone propionate (0.8 or 1.6 mg/day) or dihydrotestosterone propionate (0.2, 0.4, or 0.8 mg/day) significantly reduced the incidence of lordosis in ovariectomized females receiving estradiol benzoate (1 microgram/day). "
3.	Inflammation (Inflammations) 04/01/2006 - "All prostates in 6, 17beta-estradiol plus dihydrotestosterone propionate treated rats and in 3 of 7 controls (43%) showed inflammation foci. " 06/15/2000 - "Exposure of male Wistar rats to estradiol-17beta (E(2)) in the presence or absence of dihydrotestosterone propionate (DHT) was previously shown to result in prostate inflammation. "
4.	Tetraploidy 01/01/1979 - "A combined treatment with FSH and dihydrotestosterone propionate (DHTP) resulted in a premature start of Sertoli cell secretion of ABP into the epididymis, but in a normal appearance of haploid and tetraploid cells. "
5.	Disease Progression 08/01/1964 - "3. EFFECT OF 6-BETA-DIBROMOMETHYLENE TESTOSTERONE PROPIONATE COMPARED WITH THAT OF 2-ALPHA-METHYL DIHYDROTESTOSTERONE PROPIONATE ON CLINICAL COURSE AND METABOLISM OF SELECTED SERUM ELECTROLYTES."

Related Drugs and Biologics

1.	Testosterone Propionate
2.	estradiol 3-benzoate (estradiol benzoate)
3.	Flutamide (Eulexin)
4.	Estradiol (Delestrogen)
5.	Electrolytes

Related Therapies and Procedures

1.	Injections